Publications

• Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial.Reuben DB, Gill TM, Stevens A, Williamson J, Volpi E, Lichtenstein M, Jennings LA, Galloway R, Summapund J, Araujo K, Bass D, Weitzman L, Tan ZS, Evertson L, Yang M, Currie K, Green AS, Godoy S, Abraham S, Reese J, Samper-Ternent R, Hirst RM, Borek P, Charpentier P, Meng C, Dziura J, Xu Y, Skokos EA, He Z, Aiudi S, Peduzzi P, Greene EJ. JAMA. 2025 Jan 29; 2025 Jan 29. PMID: 39878968.
• Machine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators.Rosman L, Lampert R, Wang K, Gehi AK, Dziura J, Salmoirago-Blotcher E, Brandt C, Sears SF, Burg M. J Am Coll Cardiol. 2025 Jan 7; 2024 Nov 20. PMID: 39570241.
• Integrated Stepped Alcohol Treatment With Contingency Management for Unhealthy Alcohol Use Among People With HIV: A Randomized Controlled Trial.Edelman EJ, Dziura J, Deng Y, DePhilippis D, Ferguson T, Brown S, Marconi VC, Goetz MB, Rodriguez-Barradas MC, Simberkoff MS, Molina PE, Weintrob AC, Maisto SA, Paris M, Justice AC, Bryant KJ, Fiellin DA. J Acquir Immune Defic Syndr. 2025 Jan 1. PMID: 39321757.
• Spatiotemporal Eye Movement Dynamics Reveal Altered Face Prioritization in Early Visual Processing Among Autistic Children.Griffin JW, Naples A, Bernier R, Chawarska K, Dawson G, Dziura J, Faja S, Jeste S, Kleinhans N, Sugar C, Webb SJ, Shic F, McPartland JC. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Jan; 2024 Sep 3. PMID: 39237004.
• Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain.Rossi R, Cutter CJ, Beitel M, Covelli M, Fiellin DA, Kerns RD, Vassilieva S, Olabisi D, Barry DT. Subst Use Addctn J. 2025 Jan; 2024 Apr 12. PMID: 38606900.
• Four targets: an enhanced framework for guiding causal inference from observational data.Lu H, Li F, Lesko CR, Fink DS, Rudolph KE, Harhay MO, Rentsch CT, Fiellin DA, Gonsalves GS. Int J Epidemiol. 2024 Dec 16. PMID: 39868475.
• A Prehospital Quality Improvement Framework to Reduce Mortality and Other Harms Associated with Opioid Use Disorder.Glenn M, Crowe R, Dorsett M, Taigman M, Herring AA, Mercer M, Joiner A, Venkatesh A, Davis C, Hawk K, Hern HG, Carroll G, Cabañas JG, D'Onofrio G, Samuels EA. Prehosp Emerg Care. 2024 Dec 13; 2024 Dec 13. PMID: 39671519.
• Take-Home Naloxone, Release From Jail, and Opioid Overdose-A Piece of the Puzzle.Balter DR, Howell BA. JAMA Netw Open. 2024 Dec 2; 2024 Dec 2. PMID: 39656464.
• Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.Haque LY, Leggio L. Hepatology. 2024 Dec 1; 2024 Jun 27. PMID: 38935926.
• Guideline concordance of electronic health record order sets for hospital-based treatment of alcohol withdrawal syndrome.Cohen SM, Kashyap N, Steel TL, Edelman EJ, Fiellin DA, Joudrey PJ. J Hosp Med. 2024 Nov 24; 2024 Nov 24. PMID: 39580659.
• Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.Lu T, Ryan D, Cadet T, Chawarski MC, Coupet E, Edelman EJ, Hawk KF, Huntley K, Jalali A, O'Connor PG, Owens PH, Martel SH, Fiellin DA, D'Onofrio G, Murphy SM. Ann Emerg Med. 2024 Nov 20; 2024 Nov 20. PMID: 39570250.
• Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals.Cohen SM, Beetham T, Fiellin DA, Muvvala SB. JAMA Netw Open. 2024 Nov 4; 2024 Nov 4. PMID: 39535800.
• Recommendations for monitoring adherence and fidelity in pragmatic trials based on experience in the Pain Management Collaboratory.Dziura J, Gilstad-Hayden K, Coffman CJ, Long CR, Yu Q, Buta E, Coggeshall S, Geda M, Peduzzi P, Kyriakides TC. Pain Med. 2024 Nov 1. PMID: 39514878.
• Screening, brief intervention, and referral to treatment for pain management for veterans separating from military service: study protocol of a hybrid type 2 study testing implementation facilitation versus training-as-usual.Sellinger JJ, Rosen MI, Lazar CM, Gilstad-Hayden K, Dziura J, Li FY, Mattocks K, Weede A, Sullivan-Tibbs M, Rose L, Garcia Vassallo G, Manhapra A, Turner A, Vogt D, Woodward EN, Hartmann CW, Haskell SG, Mohammad A, Martino S. Pain Med. 2024 Nov 1. PMID: 39514877.
• Utility of the PICOTS framework to assess clinical trial disruptions: monitoring the impact of COVID-19 in the Pain Management Collaboratory.Peduzzi P, Brandt C, Dearth CL, Dziura J, Farrokhi S, George SZ, Kyriakides TC, Long CR, Mascha EJ, Patterson CG, Rhon DI, Kerns RD. Pain Med. 2024 Nov 1. PMID: 39514876.
• Adapting to change: experiences and recommendations from the Pain Management Collaboratory on modifying statistical analysis plans.Yu Q, George SZ, Kyriakides TC, Rhon DI, Morasco BJ, Dziura J, Fritz JM, Geda M, Peduzzi P, Long CR. Pain Med. 2024 Nov 1. PMID: 39514871.
• A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System.Haque LY, Tate JP, Chew M, Caniglia EC, Taddei TH, Re VL 3rd. Pharmacoepidemiol Drug Saf. 2024 Nov. PMID: 39477692.
• Epidemiology and Health Care Burden of Alcohol Use Disorder.Choi HY, Balter DR, Haque LY. Clin Liver Dis. 2024 Nov; 2024 Jul 23. PMID: 39362708.
• Prescription Opioid Dose Change Before Fatal Opioid-Detected Overdose.Kazemitabar M, Howell BA, Becker WC, Lin HJ, Grau LE, Heimer R, D'Onofrio G, Hawk K, Fiellin DA, Black AC. J Stud Alcohol Drugs. 2024 Nov; 2024 May 22. PMID: 38775307.
• Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk.Murnane PM, Afshar M, Chamie G, Cook RL, Ferguson T, Haque LY, Jacobson KR, Justice AC, Kim TW, Khalili M, Krupitsky E, McGinnis KA, Molina P, Muyindike WR, Myers B, Richards VL, So-Armah K, Stewart S, Sulkowski MS, Tien PC, Hahn JA. Am J Gastroenterol. 2024 Oct 31; 2024 Oct 31. PMID: 39480054.
• Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey.Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Hagle H, Joudrey PJ, Molfenter T, Levin FR, Fiellin DA, Edelman EJ. J Addict Med. 2024 Oct 30; 2024 Oct 30. PMID: 39475119.
• The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol.Womack JA, Leblanc MM, Sager AS, Zaets LN, Maisto SA, Garcia A, Aoun-Barakat L, Brown SE, Edelman EJ, Fiellin DA, Fisher J, Fraenkel L, Kidwai-Khan F, Marconi VC, Martino S, Pulk R, Satre DD, Virata M, Justice AC, Hsieh E. AIDS Behav. 2024 Oct 28; 2024 Oct 28. PMID: 39465468.
• Asynchronous education improves emergency medical services clinician confidence and knowledge in caring for patients near the end-of-life.Wang DH, Dunn C, Brooten JK, Gacioch B, Taigman M, He Z, Dziura J, Breyre AM. J Am Coll Emerg Physicians Open. 2024 Oct; 2024 Oct 23. PMID: 39449818.
• Harming Health by Imposing In-Prison Co-Payments.Howell BA, Resnik J, Wang EA. JAMA Intern Med. 2024 Oct 1. PMID: 39102228.
• Clinician-caregiver informant discrepancy is associated with sex, diagnosis age, and intervention use among autistic children.Azu MA, Han GT, Wolf JM, Naples AJ, Chawarska K, Dawson G, Bernier RA, Jeste SS, Dziura JD, Webb SJ, Sugar CA, Shic F, McPartland JC. Autism. 2024 Sep 30; 2024 Sep 30. PMID: 39344965.
• Trends and Disparities in Initiation of Buprenorphine in US Emergency Departments, 2013-2022.Chhabra N, Smith D, Dickinson G, Caglianone L, Taylor RA, D'Onofrio G, Karnik NS. JAMA Netw Open. 2024 Sep 3; 2024 Sep 3. PMID: 39325455.
• Treatment Failure Versus Failed Treatments: The Risks of Embracing Treatment Refractory Addiction.Fiellin DA. J Addict Med. 2024 Sep-Oct 01; 2024 Aug 10. PMID: 39356618.
• Postrelease Risk of Overdose and All-Cause Death Among Persons Released From Jail or Prison: Minnesota, March 2020-December 2021.Hill K, Bodurtha PJ, Winkelman TNA, Howell BA. Am J Public Health. 2024 Sep; 2024 Jul 18. PMID: 39024534.
• Treatment for Co-Occurring Stimulant and Opioid Use Disorders: Overcoming Barriers in the Era of Polysubstance Use.Howell BA, Lin LA, Coughlin LN. JAMA Psychiatry. 2024 Sep 1. PMID: 38985457.
• Parsing evoked and induced gamma response differences in Autism: A visual evoked potential study.Dickinson A, Ryan D, McNaughton G, Levin A, Naples A, Borland H, Bernier R, Chawarska K, Dawson G, Dziura J, Faja S, Kleinhans N, Sugar C, Senturk D, Shic F, Webb SJ, McPartland JC, Jeste S. Clin Neurophysiol. 2024 Sep; 2024 Jun 8. PMID: 38959536.
• Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial.Balter DR, Puglisi LB, Dziura J, Fiellin DA, Howell BA. J Subst Use Addict Treat. 2024 Sep; 2024 Jun 8. PMID: 38857827.
• Opportunities for Alcohol-Related Care in the COVID-19 Pandemic and Beyond.Oldfield B, Haque L, Jennifer Edelman E. J Gen Intern Med. 2024 Sep. PMID: 38671202.
• Understanding social situations: study protocol for a randomized controlled trial evaluating a novel social cognitive training versus modified problem-solving training for people with psychosis.Fiszdon JM, Bell MD, Fulford D, Roberts DL, Dziura J, Parente L, Nasse A, Choi J. Front Psychiatry. 2024; 2024 Aug 22. PMID: 39238934.
• "SafetyNet": Evaluation of a Recovery Coach and Paramedic Intervention Following Naloxone Resuscitation From an Opioid Overdose.Joseph D, Brokowski C, D'Onofrio G, Bogucki S, McGovern J, Allen R, Dziura J, Cone DC, Pantalon MV. Subst Use Addctn J. 2024 Aug 22; 2024 Aug 22. PMID: 39171791.
• Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study.Lampert R, Day S, Ainsworth B, Burg M, Marino BS, Salberg L, Tome Esteban MT, Abrams DJ, Aziz PF, Barth C, Behr ER, Bell C, Berul CI, Bos JM, Bradley D, Cannom DS, Cannon BC, Concannon MA, Cerrone M, Czosek RJ, Dubin AM, Dziura J, Erickson CC, Estes NAM 3rd, Etheridge SP, Goldenberg I, Gray B, Haglund-Turnquist C, Harmon K, James CA, Johnsrude C, Kannankeril P, Lara A, Law IH, Li F, Link MS, Molossi SM, Olshansky B, Noseworthy PA, Saarel EV, Sanatani S, Shah M, Simone L, Skinner J, Tomaselli GF, Ware JS, Webster G, Zareba W, Zipes DP, Ackerman MJ. Circulation. 2024 Aug 13; 2024 Jul 25. PMID: 39051104.
• Modeling of drinking and driving behaviors among adolescents and young adults in the United States: Complexities and Intervention outcomes.Hosseinichimeh N, MacDonald R, Li K, Fell JC, Haynie DL, Simons-Morton B, Banz BC, Camenga DR, Iannotti RJ, Curry LA, Dziura J, Andersen DF, Vaca FE. Soc Sci Med. 2024 Aug; 2024 Jul 5. PMID: 39043064.
• Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque LY, Balliet W, Serper M. Liver Transpl. 2024 Aug 1; 2024 Mar 13. PMID: 38471008.
• Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.D'Onofrio G, Herring AA, Perrone J, Hawk K, Samuels EA, Cowan E, Anderson E, McCormack R, Huntley K, Owens P, Martel S, Schactman M, Lofwall MR, Walsh SL, Dziura J, Fiellin DA. JAMA Netw Open. 2024 Jul 1; 2024 Jul 1. PMID: 38976265.
• Using qualitative system dynamics modeling to understand overdose bystander behavior in the context of Connecticut's Good Samaritan Laws and identify effective policy options.Thompson RL, Sabounchi NS, Ali SS, Heimer R, D'Onofrio G, Heckmann R. Harm Reduct J. 2024 Jun 27; 2024 Jun 27. PMID: 38937759.
• An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes.Kypriotakis G, Bernstein SL, Bold KW, Dziura JD, Hedeker D, Mermelstein RJ, Weinberger AH. Nicotine Tob Res. 2024 Jun 21. PMID: 38214037.
• Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023.Savitz ST, Stevens MA, Nath B, D'Onofrio G, Melnick ER, Jeffery MM. Mayo Clin Proc Innov Qual Outcomes. 2024 Jun; 2024 May 24. PMID: 38841599.
• The MATE Act: Progress for substance use education, but is checking a box enough?Morford KL, Tetrault JM, Fiellin DA. J Gen Intern Med. 2024 Jun; 2024 Feb 2. PMID: 38308156.
• Alcohol-Related Care Among Veterans With Unhealthy Alcohol Use: The Role of Long-Term Opioid Therapy Receipt.Joudrey PJ, Wang M, DeRycke E, Williams EC, Edelman EJ. J Addict Med. 2024 May-Jun 01; 2024 Mar 27. PMID: 38533996.
• The dementia care study (D-CARE): Recruitment strategies and demographic characteristics of participants in a pragmatic randomized trial of dementia care.Yang M, Samper-Ternent R, Volpi E, Green AN, Lichtenstein M, Araujo K, Borek P, Charpentier P, Dziura J, Gill TM, Galloway R, Greene EJ, Lenoir K, Peduzzi P, Meng C, Reese J, Shelton A, Skokos EA, Summapund J, Unger E, Reuben DB, Williamson JD, Stevens AB. Alzheimers Dement. 2024 Apr; 2024 Feb 15. PMID: 38358084.
• Feasibility of an Interprofessional Inpatient Educational Intervention for Patients With Decompensated Cirrhosis.Haque LY, McDonough M, Deng Y, Ciarleglio MM, Liapakis A, Jakab S. Gastro Hep Adv. 2024; 2024 Mar 22. PMID: 39165423.
• Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action.Haque LY, Zuluaga P, Muga R, Fuster D. Addict Sci Clin Pract. 2024 Mar 19; 2024 Mar 19. PMID: 38504384.
• Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations.McLeman B, Gauthier P, Lester LS, Homsted F, Gardner V 3rd, Moore SK, Joudrey PJ, Saldana L, Cochran G, Harris JP, Hefner K, Chongsi E, Kramer K, Vena A, Ottesen RA, Gallant T, Boggis JS, Rao D, Page M, Cox N, Iandiorio M, Ambaah E, Ghitza U, Fiellin DA, Marsch LA. Addict Sci Clin Pract. 2024 Mar 18; 2024 Mar 18. PMID: 38500166.
• Racial and Ethnic Differences in Heroin, Methamphetamine, and Cocaine Use, Treatment, and Mortality Trends in 3 National Data Sources-United States, 2010-2019.Shearer RD, Segel JE, Howell BA, Jones AA, Khatri UG, Teixeira da Silva D, Vest N, Winkelman TNA. Med Care. 2024 Mar 1; 2024 Jan 5. PMID: 38180005.
• Leveraging a Learning Collaborative Model to Develop and Pilot Quality Measures to Improve Opioid Prescribing in the Emergency Department.Hawk KF, Weiner SG, Rothenberg C, Bernstein E, D'Onofrio G, Herring A, Hoppe J, Ketcham E, LaPietra A, Nelson L, Perrone J, Ranney M, Samuels EA, Strayer R, Sharma D, Goyal P, Schuur J, Venkatesh AK. Ann Emerg Med. 2024 Mar; 2023 Oct 11. PMID: 37831040.
• Formative evaluation of an emergency department clinical decision support system for agitation symptoms: a study protocol.Wong AH, Nath B, Shah D, Kumar A, Brinker M, Faustino IV, Boyce M, Dziura JD, Heckmann R, Yonkers KA, Bernstein SL, Adapa K, Taylor RA, Ovchinnikova P, McCall T, Melnick ER. BMJ Open. 2024 Feb 19; 2024 Feb 19. PMID: 38373857.
• Accessibility of Opioid Treatment Programs Based on Conventional vs Perceived Travel Time Measures.Kim J, Lee J, Thornhill TA, Dennett J, Lu H, Howell B, Grau LE, Fiellin DA, Heimer R, Gonsalves G. JAMA Netw Open. 2024 Feb 5; 2024 Feb 5. PMID: 38376839.
• Opioid prescription and risk of atrial fibrillation in younger veterans.Chui PW, Khokhar A, Gordon KS, Dziura J, Burg MM, Brandt C, Haskell SG, Malm B, Bastian LA, Gandhi PU. Am Heart J. 2024 Feb; 2023 Nov 9. PMID: 37949420.
• A Serious Video Game Targeting HIV Testing and Counseling: A Randomized Controlled Trial.Boomer TP, Larkin K, Duncan LR, Fernandes CF, Fiellin LE. J Adolesc Health. 2024 Feb; 2023 Oct 10. PMID: 37815773.
• Association of marital/partner status with hospital readmission among young adults with acute myocardial infarction.Zhu C, Dreyer RP, Li F, Spatz ES, Caraballo C, Mahajan S, Raparelli V, Leifheit EC, Lu Y, Krumholz HM, Spertus JA, D'Onofrio G, Pilote L, Lichtman JH. PLoS One. 2024; 2024 Jan 26. PMID: 38277368.
• Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016-17.Heimer R, Black AC, Lin H, Grau LE, Fiellin DA, Howell BA, Hawk K, D'Onofrio G, Becker WC. Drug Alcohol Depend. 2024 Jan 1; 2023 Nov 28. PMID: 38043226.
• Understanding Regional Patterns of Overdose Deaths Related to Opioids and Psychostimulants.Segel JE, Shearer RD, Jones AA, Khatri UG, Howell BA, Crowley DM, Sterner G, Vest N, Teixeira da Silva D, Winkelman TNA. Subst Use Misuse. 2024; 2024 Feb 8. PMID: 38037904.
• Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder.D'Onofrio G, Perrone J, Hawk KF, Cowan E, McCormack R, Coupet E Jr, Owens PH, Martel SH, Huntley K, Walsh SL, Lofwall MR, Herring A. Acad Emerg Med. 2023 Dec; 2023 Aug 22. PMID: 37501652.
• Perspectives on and experiences of emergency department-initiated buprenorphine among clinical pharmacists: A multi-site qualitative study.Justen M, Edelman EJ, Chawarski M, Coupet E Jr, Cowan E, Lyons M, Owens P, Martel S, Richardson L, Rothman R, Whiteside L, O'Connor PG, Zahn E, D'Onofrio G, Fiellin DA, Hawk KF. J Subst Use Addict Treat. 2023 Dec; 2023 May 5. PMID: 37149149.
• Identifying Game-Based Digital Biomarkers of Cognitive Risk for Adolescent Substance Misuse: Protocol for a Proof-of-Concept Study.Aneni K, Chen CH, Meyer J, Cho YT, Lipton ZC, Kher S, Jiao MG, Gomati de la Vega I, Umutoni FA, McDougal RA, Fiellin LE. JMIR Res Protoc. 2023 Nov 23; 2023 Nov 23. PMID: 37995115.
• A Video Game Intervention to Prevent Opioid Misuse Among Older Adolescents: Development and Preimplementation Study.Aneni K, Fernandes CF, Hoerner LA, Szapary C, Pendergrass Boomer TM, Fiellin LE. JMIR Serious Games. 2023 Nov 3; 2023 Nov 3. PMID: 37921851.
• Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial.Muvvala SB, Gan G, Morford KL, Dziura J, Esserman D, Porter E, Chan PA, Cornman DH, Reynolds J, Yager JE, Fiellin DA, Edelman EJ. J Addict Med. 2023 Nov-Dec 01; 2023 Jun 16. PMID: 37934538.
• The Selective Social Attention task in children with autism spectrum disorder: Results from the Autism Biomarkers Consortium for Clinical Trials (ABC-CT) feasibility study.Shic F, Barney EC, Naples AJ, Dommer KJ, Chang SA, Li B, McAllister T, Atyabi A, Wang Q, Bernier R, Dawson G, Dziura J, Faja S, Jeste SS, Murias M, Johnson SP, Sabatos-DeVito M, Helleman G, Senturk D, Sugar CA, Webb SJ, McPartland JC, Chawarska K. Autism Res. 2023 Nov; 2023 Sep 25. PMID: 37749934.
• Yale Emergency Scholars (YES) Program: A model for expanding emergency medicine research capacity.Yang D, Panthagani K, Ryus CR, Nelson AR, Wright D, Sherak R, Bernstein SL, D'Onofrio G. Acad Emerg Med. 2023 Nov; 2023 Jul 31. PMID: 37436420.
• URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW.Cowan E, Perrone J, Dziura J, Edelman EJ, Hawk K, Herring A, McCormack R, Murphy A, Phadke M, Fiellin DA, D'Onofrio G. J Emerg Med. 2023 Oct; 2023 Jun 20. PMID: 37716904.
• Multidisciplinary Strategies for Preventing Opioid Misuse and Escalation by Targeting Mental Health Symptoms and Conditions.Yule AM, Fernandes CF, Stormshak EA, Yang Y, Shelley L, Fiellin LE, Larkin K, Ridenour TA, Saavedra LM, Kelleher K, Feng X, Walton MA, Bonar EE. Prev Sci. 2023 Oct; 2023 Jun 2. PMID: 37266870.
• Health Insurance and Mental Health Treatment Use Among Adults With Criminal Legal Involvement After Medicaid Expansion.Howell BA, Hawks LC, Balasuriya L, Chang VW, Wang EA, Winkelman TNA. Psychiatr Serv. 2023 Oct 1; 2023 Apr 5. PMID: 37016823.
• Methodological Strategies for Prospective Harmonization of Studies: Application to 10 Distinct Outcomes Studies of Preventive Interventions Targeting Opioid Misuse.Ridenour TA, Cruden G, Yang Y, Bonar EE, Rodriguez A, Saavedra LM, Hussong AM, Walton MA, Deeds B, Ford JL, Knight DK, Haggerty KP, Stormshak E, Kominsky TK, Ahrens KR, Woodward D, Feng X, Fiellin LE, Wilens TE, Klein DJ, Fernandes CS. Prev Sci. 2023 Oct; 2022 Aug 17. PMID: 35976525.
• Computational phenotypes for patients with opioid-related disorders presenting to the emergency department.Taylor RA, Gilson A, Schulz W, Lopez K, Young P, Pandya S, Coppi A, Chartash D, Fiellin D, D'Onofrio G. PLoS One. 2023; 2023 Sep 15. PMID: 37713393.
• A digital health game to prevent opioid misuse and promote mental health in adolescents in school-based health settings: Protocol for the PlaySmart game randomized controlled trial.Pendergrass Boomer TM, Hoerner LA, Fernandes CF, Maslar A, Aiudi S, Kyriakides TC, Fiellin LE. PLoS One. 2023; 2023 Sep 8. PMID: 37683047.
• Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy.Cartwright EJ, Pierret C, Minassian C, Esserman DA, Tate JP, Goetz MB, Bhattacharya D, Fiellin DA, Justice AC, Lo Re V 3rd, Rentsch CT. JAMA Netw Open. 2023 Sep 5; 2023 Sep 5. PMID: 37751206.
• Impact of Marital Stress on 1-Year Health Outcomes Among Young Adults With Acute Myocardial Infarction.Zhu C, Dreyer RP, Li F, Spatz ES, Caraballo-Cordovez C, Mahajan S, Raparelli V, Leifheit EC, Lu Y, Krumholz HM, Spertus JA, D'Onofrio G, Pilote L, Lichtman JH. J Am Heart Assoc. 2023 Sep 5; 2023 Aug 17. PMID: 37589125.
• Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States.Joudrey PJ, Chen K, Oldfield BJ, Biegacki E, Fiellin DA. J Addict Med. 2023 Sep-Oct 01; 2023 Apr 21. PMID: 37788621.
• Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys.Chen K, Oldfield BJ, Joudrey PJ, Biegacki ET, Fiellin DA. J Addict Med. 2023 Sep-Oct 01; 2023 May 8. PMID: 37788607.
• Perspectives on contingency management for alcohol use and alcohol-associated conditions among people in care with HIV.Cohen SM, DePhilippis D, Deng Y, Dziura J, Ferguson T, Fucito LM, Justice AC, Maisto S, Marconi VC, Molina P, Paris M, Rodriguez-Barradas MC, Simberkoff M, Petry NM, Fiellin DA, Edelman EJ. Alcohol Clin Exp Res (Hoboken). 2023 Sep; 2023 Aug 29. PMID: 37524371.
• Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021.Shearer RD, Howell BA, Khatri UG, Winkelman TNA. Drug Alcohol Depend Rep. 2023 Sep; 2023 Jul 12. PMID: 37502021.
• National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder.Cowan E, Perrone J, Bernstein SL, Coupet E Jr, Fiellin DA, Hawk K, Herring A, Huntley K, McCormack R, Venkatesh A, D'Onofrio G. Ann Emerg Med. 2023 Sep; 2023 May 12. PMID: 37178101.
• Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial.McCormack RP, Rotrosen J, Gauthier P, D'Onofrio G, Fiellin DA, Marsch LA, Novo P, Liu D, Edelman EJ, Farkas S, Matthews AG, Mulatya C, Salazar D, Wolff J, Knight R, Goodman W, Williams J, Hawk K. Ann Emerg Med. 2023 Sep; 2023 May 2. PMID: 37140493.
• ACEP-SAEM response to the National Institutes of Health (NIH) proposal to simplify the review framework for research project grant applications.Knack SK, Kim H, Paxton J, Garg N, Lumba-Brown A, Levy P, Puskarich M, Silbergleit R, D'Onofrio G, Adeoye O, Kang C, Diercks D, Neumar R, Sharp WW. Acad Emerg Med. 2023 Sep; 2023 Apr 21. PMID: 36995344.
• Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial.Edelman EJ, Dziura J, Deng Y, DePhilippis D, Fucito LM, Ferguson T, Bedimo R, Brown S, Marconi VC, Goetz MB, Rodriguez-Barradas MC, Simberkoff MS, Molina PE, Weintrob AC, Maisto SA, Paris M, Justice AC, Bryant KJ, Fiellin DA. Contemp Clin Trials. 2023 Aug; 2023 May 23. PMID: 37230168.
• Separate But Not Equal? A Cross-Sectional Study of Segregation by Payor Mix in Academic Primary Care Clinics.Hassan SF, Viscoli CM, O'Connor PG, Dugdale LS, Sofair AN, Fitz MM, Richards B, Feiereisel KB, Lee SY, Ost SR, Swails JL, Fishman MB, Kernan WN. J Gen Intern Med. 2023 Aug; 2023 Feb 17. PMID: 36800147.
• Attention Allocation During Exploration of Visual Arrays in ASD: Results from the ABC-CT Feasibility Study.Tsang T, Naples AJ, Barney EC, Xie M, Bernier R, Dawson G, Dziura J, Faja S, Jeste SS, McPartland JC, Nelson CA, Murias M, Seow H, Sugar C, Webb SJ, Shic F, Johnson SP. J Autism Dev Disord. 2023 Aug; 2022 Jun 3. PMID: 35657448.
• Fentanyl-Associated Overdose Deaths Outside the Hospital.Jeffery MM, Stevens M, D'Onofrio G, Melnick ER. N Engl J Med. 2023 Jul 6; 2023 Jun 21. PMID: 37342960.
• Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey.Oldfield BJ, Chen K, Joudrey PJ, Biegacki ET, Fiellin DA. J Addict Med. 2023 Jul-Aug 01; 2023 Mar 16. PMID: 37579115.
• Cost-Effectiveness of Smoking Cessation Approaches in Emergency Departments.Miller TR, Johnson MB, Dziura JD, Weiss J, Carpenter KM, Grau LE, Pantalon MV, Abroms L, Collins LM, Toll BA, Bernstein SL. Am J Prev Med. 2023 Jul; 2023 Jan 28. PMID: 36710199.
• Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.Holland WC, Li F, Nath B, Jeffery MM, Stevens M, Melnick ER, Dziura JD, Khidir H, Skains RM, D'Onofrio G, Soares WE 3rd. Acad Emerg Med. 2023 Jul; 2023 Feb 27. PMID: 36660800.
• Association of Marital/Partner Status with Hospital Readmission Among Young Adults With Acute Myocardial Infarction.Zhu C, Dreyer RP, Li F, Spatz ES, Caraballo C, Mahajan S, Raparelli V, Leifheit EC, Lu Y, Krumholz HM, Spertus JA, D'Onofrio G, Pilote L, Lichtman JH. medRxiv. 2023 Jun 27; 2023 Jun 27. PMID: 37425864.
• Sex Differences in Symptom Complexity and Door-to-Balloon Time in Patients With ST-Elevation Myocardial Infarction.Brush JE Jr, Chaudhry SI, Dreyer RP, D'Onofrio G, Greene EJ, Hajduk AM, Lu Y, Krumholz HM. Am J Cardiol. 2023 Jun 15; 2023 Apr 14. PMID: 37062667.
• Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysis.Kane JC, Allen I, Fatch R, Scheffler A, Emenyonu N, Puryear SB, Chirayil P, So-Armah K, Kahler CW, Magidson JF, Conroy AA, Edelman EJ, Woolf-King S, Parry C, Kiene SM, Chamie G, Adong J, Go VF, Cook RL, Muyindike W, Morojele N, Blokhina E, Krupitsky E, Fiellin DA, Hahn JA. BMJ Open. 2023 Jun 6; 2023 Jun 6. PMID: 37280036.
• Modeling human health behavior with a new index that measures connectivity.Bernstein SL, Li F, Abujarad F, Grant DR, D'Onofrio G, Dziura J. Prev Med Rep. 2023 Jun; 2023 Mar 15. PMID: 37223571.
• Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy.Lampert R, Ackerman MJ, Marino BS, Burg M, Ainsworth B, Salberg L, Tome Esteban MT, Ho CY, Abraham R, Balaji S, Barth C, Berul CI, Bos M, Cannom D, Choudhury L, Concannon M, Cooper R, Czosek RJ, Dubin AM, Dziura J, Eidem B, Emery MS, Estes NAM, Etheridge SP, Geske JB, Gray B, Hall K, Harmon KG, James CA, Lal AK, Law IH, Li F, Link MS, McKenna WJ, Molossi S, Olshansky B, Ommen SR, Saarel EV, Saberi S, Simone L, Tomaselli G, Ware JS, Zipes DP, Day SM. JAMA Cardiol. 2023 Jun 1. PMID: 37195701.
• Mixed methods evaluation of vaping and tobacco product use prevention interventions among youth in the Florida 4-H program.Bteddini DS, LeLaurin JH, Chi X, Hall JM, Theis RP, Gurka MJ, Lee JH, Mobley EM, Khalil GE, Polansky CJ, Kellner AM, Fahnlander AM, Kelder SH, Fiellin LE, Gutter MS, Shenkman EA, Salloum RG. Addict Behav. 2023 Jun; 2023 Feb 3. PMID: 36753933.
• Sex Difference in Outcomes of Acute Myocardial Infarction in Young Patients.Sawano M, Lu Y, Caraballo C, Mahajan S, Dreyer R, Lichtman JH, D'Onofrio G, Spatz E, Khera R, Onuma O, Murugiah K, Spertus JA, Krumholz HM. J Am Coll Cardiol. 2023 May 9. PMID: 37137590.
• Effect of a Home Health and Safety Intervention on Emergency Department Use in the Frail Elderly: A Prospective Observational Study.Bogucki S, Siddiqui G, Carter R, McGovern J, Dziura J, Gan G, Li F, Stover G, Cone DC, Brokowski C, Joseph D. West J Emerg Med. 2023 May 3; 2023 May 3. PMID: 37278776.
• Young Women With Acute Myocardial Infarction: Risk Prediction Model for 1-Year Hospital Readmission.Dreyer RP, Arakaki A, Raparelli V, Murphy TE, Tsang SW, D'Onofrio G, Wood M, Wright CX, Pilote L. CJC Open. 2023 May; 2022 Dec 19. PMID: 37377522.
• Use of an Automated Bilingual Digital Health Tool to Reduce Unhealthy Alcohol Use Among Latino Emergency Department Patients: A Randomized Clinical Trial.Vaca FE, Dziura J, Abujarad F, Pantalon M, Hsiao A, Reynolds J, Maciejewski KR, Field CA, D'Onofrio G. JAMA Netw Open. 2023 May 1; 2023 May 1. PMID: 37219901.
• Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.Sue KL, Chawarski M, Curry L, McNeil R, Coupet E Jr, Schwartz RP, Wilder C, Tsui JI, Hawk KF, D'Onofrio G, O'Connor PG, Fiellin DA, Edelman EJ. JAMA Netw Open. 2023 May 1; 2023 May 1. PMID: 37163263.
• Evaluation of clinical assessments of social abilities for use in autism clinical trials by the autism biomarkers consortium for clinical trials.Faja S, Sabatos-DeVito M, Sridhar A, Kuhn JL, Nikolaeva JI, Sugar CA, Webb SJ, Bernier RA, Sikich L, Hellemann G, Senturk D, Naples AJ, Shic F, Levin AR, Seow HA, Dziura JD, Jeste SS, Chawarska K, Nelson CA 3rd, Dawson G, McPartland JC. Autism Res. 2023 May; 2023 Mar 16. PMID: 36929131.
• Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials.Shurtz L, Schwartz C, DiStefano C, McPartland JC, Levin AR, Dawson G, Kleinhans NM, Faja S, Webb SJ, Shic F, Naples AJ, Seow H, Bernier RA, Chawarska K, Sugar CA, Dziura J, Senturk D, Santhosh M, Jeste SS. Autism. 2023 May; 2022 Sep 9. PMID: 36086805.
• Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.D'Onofrio G, Edelman EJ, Hawk KF, Chawarski MC, Pantalon MV, Owens PH, Martel SH, Rothman R, Saheed M, Schwartz RP, Cowan E, Richardson L, Salsitz E, Lyons MS, Freiermuth C, Wilder C, Whiteside L, Tsui JI, Klein JW, Coupet E, O'Connor PG, Matthews AG, Murphy SM, Huntley K, Fiellin DA. JAMA Netw Open. 2023 Apr 3; 2023 Apr 3. PMID: 37017967.
• Time to Treat Alcohol Use Disorder in the Emergency Department.Hawk KF, D'Onofrio G. Ann Emerg Med. 2023 Apr; 2023 Feb 11. PMID: 36775724.